Alexis Valenzuela Espinoza

Alexis Valenzuela Espinoza

Auto-generated profile, based on publicly available information

Alexis Valenzuela Espinoza

Center for Neurosciences (C4N), Vrije Universiteit Brussel (VUB), Brussels, Belgium

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LYLaetitia Yperzeele
Laetitia Yperzeele
RHRobbert-Jan Van Hooff
Robbert-Jan Van Hooff
ASAnn De Smedt
Ann De Smedt
AEAlexis Valenzuela Espinoza
Alexis Valenzuela Espinoza
RDRita Van Dyck
Rita Van Dyck
RBRaf Brouns
Raf Brouns
Telemedicine is currently mainly applied as an in-hospital service, but this technology also holds potential to improve emergency care in the prehospital arena. We report on the safety, feasibility and reliability of in-ambulance teleconsultation using a telemedicine system of the third generation. A routine ambulance was equipped with a system for real-time bidirectional audio-video communication, automated transmission of vital parameters, glycemia and electronic patient identification. All patients ( ≥18 years) transported during emergency missions by a Prehospital Intervention Team of the Universitair Ziekenhuis Brussel were eligible for inclusion. To guarantee mobility and to facilitate 24/7 availability, the teleconsultants used lightweight laptop computers to access a dedicated telemedicine platform, which also provided functionalities for neurological assessment, electronic reporting and prehospital notification of the in-hospital team. Key registrations included any safety issue, mobile connectivity, communication of patient information, audiovisual quality, user-friendliness and accuracy of the prehospital diagnosis. Prehospital teleconsultation was obtained in 41 out of 43 cases (95.3%). The success rates for communication of blood pressure, heart rate, blood oxygen saturation, glycemia, and electronic patient identification were 78.7%, 84.8%, 80.6%, 64.0%, and 84.2%. A preliminary prehospital diagnosis was formulated in 90.2%, with satisfactory agreement with final in-hospital diagnoses. Communication of a prehospital report to the in-hospital team was successful in 94.7% and prenotification of the in-hospital team via SMS in 90.2%. Failures resulted mainly from limited mobile connectivity and to a lesser extent from software, hardware or human error. The user acceptance was high. Ambulance-based telemedicine of the third generation is safe, feasible and reliable but further research and development, especially with regard to high speed broadband access, is needed before this approach can be implemented in daily practice.

1 October 2013 in Stroke
Verified
Journal Article
Closed access
RHRobbert-Jan Van Hooff
Robbert-Jan Van Hooff
MCMelissa Cambron
Melissa Cambron
RDRita Van Dyck
Rita Van Dyck
ASAnn De Smedt
Ann De Smedt
MMMaarten Moens
Maarten Moens
RBRaf Brouns
Raf Brouns
Background and Purpose—: We evaluated the feasibility and the reliability of remote stroke severity quantification in the prehospital setting using the Unassisted TeleStroke Scale (UTSS) via a telestroke ambulance system and a fourth-generation mobile network. Methods—: The technical feasibility and the reliability of the UTSS were studied in healthy volunteers mimicking 41 stroke syndromes during ambulance transportation. Results—: Except for 1 issue, high-quality telestroke assessment was feasible in all scenarios. The mean examination time for the UTSS was 3.1 minutes (SD, 0.4). The UTSS showed excellent intrarater and interrater variability (ρ=0.98 and 0.97; P <0.001), as well as excellent internal consistency and rater agreement. Adequate concurrent validity can be derived from the strong correlation between the UTSS and the National Institutes of Health Stroke Scale (ρ=0.90; P <0.001). Conclusions—: Remote assessment of stroke severity in fast-moving ambulances using a system dedicated to prehospital telemedicine, 4G technology, and the UTSS is feasible and reliable.

6 August 2014 in Cerebrovascular Diseases
Verified
Journal Article
Closed access
LYLaetitia Yperzeele
Laetitia Yperzeele
RHRobbert-Jan Van Hooff
Robbert-Jan Van Hooff
ASAnn De Smedt
Ann De Smedt
AEAlexis Valenzuela Espinoza
Alexis Valenzuela Espinoza
RCRohny Van de Casseye
Rohny Van de Casseye
RBRaf Brouns
Raf Brouns
Background: The global burden of stroke is immense, both in medical and economic terms. With the aging population and the ongoing industrialization of the third world, stroke prevalence is expected to increase and will have a major effect on national health expenditures. Currently, the medical treatment for acute ischemic stroke is limited to intravenous recombinant tissue plasminogen activator (IV r-tPA), but its time dependency leads to low utilization rates in routine clinical practice. Prehospital delay contributes significantly to delayed or missed treatment opportunities in acute stroke. State-of-the-art acute stroke care, starting in the prehospital phase, could thereby reduce the disease burden and its enormous financial costs. Summary: The first part of this review focuses on current education measures for the general public, the emergency medical services (EMS) dispatchers and paramedics. Although much has been expected of these measures to improve stroke care, no major effects on prehospital delay or missed treatment opportunities have been demonstrated over the years. Most interventional studies showed little or no effect on the onset-to-door time, IV r-tPA utilization rates or outcome, except for prenotification of the receiving hospital by the EMS. No data are currently available on the cost-effectiveness of these commonly used measures. In the second part, we discuss new developments for the improvement of prehospital stroke diagnosis and treatment which could open new perspectives in the nearby future. These include the implementation of prehospital telestroke and the deployment of mobile stroke units. These approaches may improve patient care and could serve as a platform for prehospital clinical trials. Other opportunities include the implementation of noninvasive diagnostics (like transcranial ultrasound and blood-borne biomarkers) and the reevaluation of neuroprotective strategies in the prehospital phase. Key Messages: Timely initiation of treatment can effectively reduce the medical and economic burden of stroke and should begin with optimal prehospital stroke care. For this, prehospital telemedicine is a particularly attractive approach because it is a scalable solution that has the potential to rapidly optimize acute stroke care at limited cost.

8 March 2016 in Cerebrovascular Diseases
Verified
Journal Article
Closed access
AEAlexis Valenzuela Espinoza
Alexis Valenzuela Espinoza
RHRobbert-Jan Van Hooff
Robbert-Jan Van Hooff
ASAnn De Smedt
Ann De Smedt
MMMaarten Moens
Maarten Moens
LYLaetitia Yperzeele
Laetitia Yperzeele
FPfor the PreSSUB-Consortium
for the PreSSUB-Consortium
Background: In-ambulance telemedicine is a recently developed and a promising approach to improve emergency care. We implemented the first ever 24/7 in-ambulance telemedicine service for acute stroke. We report on our experiences with the development and pilot testing of the Prehospital Stroke Study at the Universitair Ziekenhuis Brussel (PreSSUB) to facilitate a wider spread of the knowledge regarding this technique. Methods: Successful execution of the project involved the development and validation of a novel stroke scale, design and creation of specific hardware and software solutions, execution of field tests for mobile internet connectivity, design of new care processes and information flows, recurrent training of all professional caregivers involved in acute stroke management, extensive testing on healthy volunteers, organisation of a 24/7 teleconsultation service by trained stroke experts and 24/7 technical support, and resolution of several legal issues. Results: In all, it took 41 months of research and development to confirm the safety, technical feasibility, reliability, and user acceptance of the PreSSUB approach. Stroke-specific key information can be collected safely and reliably before and during ambulance transportation and can adequately be communicated with the inhospital team awaiting the patient. Conclusion: This paper portrays the key steps required and the lessons learned for successful implementation of a 24/7 expert telemedicine service supporting patients with acute stroke during ambulance transportation to the hospital.

17 August 2018 in Neuromodulation: Technology at the Neural Interface
Verified
Journal Article
Closed access
PDF file
MMMaarten Moens
Maarten Moens
Lisa GoudmanLisa Goudman
Lisa Goudman
RBRaf Brouns
Raf Brouns
AEAlexis Valenzuela Espinoza
Alexis Valenzuela Espinoza
MJMats De Jaeger
Mats De Jaeger
JVJan Verlooy
Jan Verlooy

30 May 2017 in Anesthesiology and Pain Medicine
Verified
Journal Article
Open access
PDF file
MJMats De Jaeger
Mats De Jaeger
RHRobbert-Jan van Hooff
Robbert-Jan van Hooff
Lisa GoudmanLisa Goudman
Lisa Goudman
AEAlexis Valenzuela Espinoza
Alexis Valenzuela Espinoza
RBRaf Brouns
Raf Brouns
MMMaarten Moens
Maarten Moens
Background: Spinal cord stimulation (SCS) is a proven and effective treatment for neuropathic pain conditions such as failed back surgery syndrome (FBSS). The hypothesis that different settings for SCS parameters activate unique, pain-relieving mechanisms has boosted the development of various SCS paradigms. High density spinal cord stimulation (HD-SCS) is one of those promising, novel stimulation forms characterized by subthreshold stimulation, delivering more pulses per second and a higher pulse density to the spinal cord than conventional SCS. Objectives: The aim of DISCOVER is to gather evidence about the effectiveness, feasibility, and (possible) side effects of HD stimulation. Methods: The prospective, non-interventional, multi-center, clinical study, DISCOVER, is currently restricted to Belgium where 19 neuromodulation centers were selected. Patient recruitment started in October 2016 and is expected to end in October 2017. Subjects included are (1) patients with insufficient pain relief from conventional SCS or (2) neurostimulation-naïve patients suited for SCS. Patients will be assessed 1 month, 3 months, and 12 months after conversion to HD-SCS settings. Each patient’s visit will include: a numerical rating scale (NRS), Oswestry disability index (ODI), Pittsburgh sleep quality index (PSQI), EQ-5D, a pain map, registration of SCS settings, and a list of used pain medication. Conclusions: Although promising results have been reported, adequate registration of its effectiveness and (possible) side-effects remains an unmet need. Main results are expected in 2019. Keywords: Spinal Cord Stimulation; High Density; Failed Back Surgery Syndrome; Neuromodulation